RSV vaccines slash infections: data show jabs' staggering success against dangerous virus
Reported byNature News ↗·Sourced by Goodlede
Denmark's nationwide RSV vaccination programme for pregnant people, launched October 2025, cut infant hospital admissions dramatically; similar vaccines and monoclonal antibody treatments have now been approved across Europe, Asia, and North and South America, with the WHO estimating RSV kills about 100,000 children under 5 yearly, mostly in low- and middle-income countries.
Most deaths occur in low- and middle-income countries where vaccine access remains limited; expansion to these regions is still needed.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at Nature News
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Health
Health Canada approves first functional cure for some chronic hepatitis B patients
CBC Health · Verified
Animals
Belize secures final link in critical wildlife corridor connecting Mesoamerica's largest forest block
Re:wild · Verified
Animals
Grad student finds New Mexico's first Canada lynx in 25 years
Popular Science · Verified